P782: A PHASE 2, RANDOMIZED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

Bibliographic Details
Main Authors: Jun-Ho Jang, Raymond Wong, Rodrigo Pavani, Lisa Aurand, Quang P. Nguyen, Lorah Perlee, Amal Souttou, Jonathan Weyne, Richard Kelly
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000970032.01817.07
_version_ 1797281577141534720
author Jun-Ho Jang
Raymond Wong
Rodrigo Pavani
Lisa Aurand
Quang P. Nguyen
Lorah Perlee
Amal Souttou
Jonathan Weyne
Richard Kelly
author_facet Jun-Ho Jang
Raymond Wong
Rodrigo Pavani
Lisa Aurand
Quang P. Nguyen
Lorah Perlee
Amal Souttou
Jonathan Weyne
Richard Kelly
author_sort Jun-Ho Jang
collection DOAJ
first_indexed 2024-03-07T16:59:25Z
format Article
id doaj.art-d94b44a429864d05ac0d776924e7033d
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:59:25Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-d94b44a429864d05ac0d776924e7033d2024-03-03T03:26:14ZengWileyHemaSphere2572-92412023-08-017e018170710.1097/01.HS9.0000970032.01817.07202308003-00682P782: A PHASE 2, RANDOMIZED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIAJun-Ho Jang0Raymond Wong1Rodrigo Pavani2Lisa Aurand3Quang P. Nguyen4Lorah Perlee5Amal Souttou6Jonathan Weyne7Richard Kelly81 Samsung Medical Center, Seoul, Korea, Rep. of South2 Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong3 Regeneron Pharmaceuticals, Inc., Tarrytown, United States3 Regeneron Pharmaceuticals, Inc., Tarrytown, United States3 Regeneron Pharmaceuticals, Inc., Tarrytown, United States3 Regeneron Pharmaceuticals, Inc., Tarrytown, United States3 Regeneron Pharmaceuticals, Inc., Tarrytown, United States3 Regeneron Pharmaceuticals, Inc., Tarrytown, United States4 St James’s University Hospital, Leeds, United Kingdomhttp://journals.lww.com/10.1097/01.HS9.0000970032.01817.07
spellingShingle Jun-Ho Jang
Raymond Wong
Rodrigo Pavani
Lisa Aurand
Quang P. Nguyen
Lorah Perlee
Amal Souttou
Jonathan Weyne
Richard Kelly
P782: A PHASE 2, RANDOMIZED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
HemaSphere
title P782: A PHASE 2, RANDOMIZED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
title_full P782: A PHASE 2, RANDOMIZED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
title_fullStr P782: A PHASE 2, RANDOMIZED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
title_full_unstemmed P782: A PHASE 2, RANDOMIZED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
title_short P782: A PHASE 2, RANDOMIZED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
title_sort p782 a phase 2 randomized trial evaluating the safety and efficacy of pozelimab and cemdisiran in patients with paroxysmal nocturnal hemoglobinuria
url http://journals.lww.com/10.1097/01.HS9.0000970032.01817.07
work_keys_str_mv AT junhojang p782aphase2randomizedtrialevaluatingthesafetyandefficacyofpozelimabandcemdisiraninpatientswithparoxysmalnocturnalhemoglobinuria
AT raymondwong p782aphase2randomizedtrialevaluatingthesafetyandefficacyofpozelimabandcemdisiraninpatientswithparoxysmalnocturnalhemoglobinuria
AT rodrigopavani p782aphase2randomizedtrialevaluatingthesafetyandefficacyofpozelimabandcemdisiraninpatientswithparoxysmalnocturnalhemoglobinuria
AT lisaaurand p782aphase2randomizedtrialevaluatingthesafetyandefficacyofpozelimabandcemdisiraninpatientswithparoxysmalnocturnalhemoglobinuria
AT quangpnguyen p782aphase2randomizedtrialevaluatingthesafetyandefficacyofpozelimabandcemdisiraninpatientswithparoxysmalnocturnalhemoglobinuria
AT lorahperlee p782aphase2randomizedtrialevaluatingthesafetyandefficacyofpozelimabandcemdisiraninpatientswithparoxysmalnocturnalhemoglobinuria
AT amalsouttou p782aphase2randomizedtrialevaluatingthesafetyandefficacyofpozelimabandcemdisiraninpatientswithparoxysmalnocturnalhemoglobinuria
AT jonathanweyne p782aphase2randomizedtrialevaluatingthesafetyandefficacyofpozelimabandcemdisiraninpatientswithparoxysmalnocturnalhemoglobinuria
AT richardkelly p782aphase2randomizedtrialevaluatingthesafetyandefficacyofpozelimabandcemdisiraninpatientswithparoxysmalnocturnalhemoglobinuria